Technology | June 11, 2013

Siemens Introduces Continuous FlowMotion PET/CT

Biograph mCT Flow is the first PET/CT system with continuous motion scanning to improve image detail

June 11, 2013 — Siemens Healthcare has introduced Biograph mCT Flow, a positron emission tomography/computed tomography (PET/CT) system that, for the first time ever, overcomes the limitations of conventional bed-based PET/CT with FlowMotion, a new technology that moves the patient smoothly through the system’s gantry, while continuously acquiring PET data. Biograph mCT Flow with FlowMotion takes routine image quality to a new level by enabling imaging protocols based on the organ’s need.

FlowMotion expands quantification in all dimensions for precise disease characterization in therapy monitoring, while enabling physicians to offer as low as reasonably achievable (ALARA) dose to every patient. Additionally, the combination of a 78 centimeter bore with five-minute scanning and a continuous sense of progress throughout the scan provides the patient with a more comfortable exam experience.

Finest detail in every organ

With conventional PET/CT scanners, planning and scanning is limited to the fixed size of the system’s detector field of view (FOV) for each bed position. While the adjustment of scan parameters in clinical stop-and-go PET/CT protocols is technically possible, the complexity of adjustment has limited its routine use.

Biograph mCT Flow PET/CT with FlowMotion technology eliminates the need for stop-and-go, bed-based planning with planning and scanning based on the single continuous motion of the patient table. The technician can easily adjust the examination parameters such as speed, image resolution and motion management to the precise dimensions of organs and routinely incorporated into a single scan for every patient.
 
Accurate quantification in all dimensions

In order to help physicians make sound decisions, nuclear imaging must provide accurate and reproducible quantification. Conventional PET/CT suffers from intrinsic sensitivity degradation from the center to the edge of the axial FOV. Overlapping sequential bed positions are used to compensate for this constraint, but this approach can lead to axially varying noise sensitivity.  This noise can distort the quantitative values of a detected lesion, which may prompt a physician to mischaracterize the severity of a tumor. By continuously moving the patient through the detection system, FlowMotion technology eliminates overlapping bed acquisitions and maintains uniform noise sensitivity across the entire scan range.

Minimum dose and maximum speed

FlowMotion eliminates CT dose due to overscanning by enabling the user to precisely define the beginning and end of the PET scan – and since the CT scan of Biograph mCT Flow begins and ends at the same points as the system’s PET scan, the patient is not irradiated in areas of the body that do not require a CT scan. With Biograph mCT Flow, the user can realize a CT dose reduction of up to 32 percent. Meanwhile, the new Biograph mCT Flow, coupled with TrueV, enables continuous scanning at twice the speed of conventional PET/CT. TrueV technology provides a 30 percent wider axial FOV of 21.6 cm, enabling Biograph mCT Flow to provide a 70 percent increase in count rate performance. When combined with ultraHD/PET, which delivers increased image quality, routine clinical scans can be performed in five minutes. The user can employ a simple protocol setup to determine the scan type and duration for up to four zones — for example, the head, lungs, abdomen and legs. The user can then tailor the scan in each region using Siemens’ established image quality techniques.

Open comfort for all patients

Healthcare providers require a system that accommodates the individual needs of a wide patient demographic. A standard PET/CT scan can last 25 to 30 minutes, with the patient frequently falling asleep or zoning out while the system acquires a bed position. When the bed shifts to the next scanning position, the patient is often startled, resulting in an image that is marred by motion artifacts. The patient also can feel anxiety during the lengthy scanning process, perceiving no progress until the bed shifts to a new scanning position.

In addition to the elimination of patient motion due to surprise, the continuously moving patient table of Biograph mCT Flow gives the patients a sense of progress, which can further enhance patient satisfaction.  Additionally, the large 78 cm bore, short tunnel and a 500 pound table capacity can improve patient comfort and accessibility.

For more information: usa.healthcare.siemens.com

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a
Sponsored Content | Videos | Clinical Decision Support | June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Dual-Agent PET/MR With Time of Flight Detects More Cancer

Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.

News | PET-MRI | June 20, 2017
Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (...
Combined Optical and Molecular Imaging Could Guide Breast-Conserving Surgery

WLE specimen from a patient with a grade 3, ER-/HER2-, no special type (NST) carcinoma. (A) Cerenkov image; (B) Grey-scale photographic image overlaid with Cerenkov signal. An increased signal from the tumor is visible (white arrows); mean radiance is 871 ± 131 photons/s/cm2/sr, mean TBR is 3.22. Both surgeons measured the posterior margin (outlined in blue) as 2 mm (small arrow); a cavity shaving would have been performed if the image had been available intraoperatively. The medial margin (outlined in green) measured >5 mm by both surgeons. Pathology ink prevented assessing the lateral margin; a phosphorescent signal is visible (open arrows). (C) Specimen radiography image. The absence of one surgical clip to mark the anterior margin, and the odd position of the superior margin clip (white arrow) prevented reliable margin assessment. (D) Combined histopathology image from two adjacent pathology slides on which the posterior margin (bottom of image) and part of the primary tumor are visible (open arrows). The distance from the posterior margin measured 3 mm microscopically (double arrow). The medial margin is > 5 mm (not present in image). Credit: A. D. Purushotham, M.D., King’s College London, UK

News | Nuclear Imaging | June 20, 2017
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage...
A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging

A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging. Graphic courtesy of the Department of Nuclear Medicine, Royal North Shore Hospital, Sydney

News | Prostate Cancer | June 15, 2017
An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific...
Overlay Init